JACC. Case reports · 2025
Managing Acute Myocardial Infarction in Shock and Anemia.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Madanchi Mehdi, Belley-Côté Emilie P, Bansal Arushi, Maiorano Silvia, Tsang Michael B
Аннотация
BACKGROUND: Patients presenting with ST-segment elevation myocardial infarction (STEMI) and concurrent anemia or active bleeding present a therapeutic dilemma.
CASE SUMMARY: A 61-year-old woman with a history of pulmonary embolism and a newly discovered lung mass presented with inferior STEMI, critically low hemoglobin level, and hemodynamic instability. Coronary angiography revealed thrombotic occlusion of the posterior left ventricular and posterior descending artery. Revascularization was performed using a drug-eluting balloon (DEB)-only strategy.
DISCUSSION: This case illustrates the need for individualized treatment in STEMI patients with cardiogenic shock and high bleeding risk. A DEB-only strategy can be a valuable approach when prolonged antiplatelet therapy is not feasible.
TAKE HOME MESSAGES: STEMI in anemic patients poses a major diagnostic challenge. Balancing thrombotic and bleeding risk is a common and challenging aspect of STEMI care. In this setting, the use of DEBs can be a viable alternative to stent implantation for patients with active bleeding.
CASE SUMMARY: A 61-year-old woman with a history of pulmonary embolism and a newly discovered lung mass presented with inferior STEMI, critically low hemoglobin level, and hemodynamic instability. Coronary angiography revealed thrombotic occlusion of the posterior left ventricular and posterior descending artery. Revascularization was performed using a drug-eluting balloon (DEB)-only strategy.
DISCUSSION: This case illustrates the need for individualized treatment in STEMI patients with cardiogenic shock and high bleeding risk. A DEB-only strategy can be a valuable approach when prolonged antiplatelet therapy is not feasible.
TAKE HOME MESSAGES: STEMI in anemic patients poses a major diagnostic challenge. Balancing thrombotic and bleeding risk is a common and challenging aspect of STEMI care. In this setting, the use of DEBs can be a viable alternative to stent implantation for patients with active bleeding.